CDER’s Quality Management Maturity Program
2022 Public Workshop

The FDA is developing a program to assess and rate the quality management maturity (QMM) of facilities manufacturing drug products and active pharmaceutical ingredients. A successful QMM rating program will improve supply chain transparency, inform purchasing decisions, reduce drug shortages, and increase medicine availability.

HOVIONE PRESENTATION

Tuesday, May 24, 2022
3:20 pm – 3:35 pm - QMM Foreign Pilot: Participant Perspective
(Eastern - EDT UTC-4)

Nuno Matos Corporate Quality Director, Quality Systems Management

Register for this event here

Find more details about the FDA Workshop at FDA.gov

You might be interested in:

• Hovione's Quality Culture

• Continuous Manufacturing